Among Chinese hypertensive patients, only 27.46% demonstrated satisfactory adherence to their antihypertensive treatment, with male gender, rural residence, and shorter disease duration identified as independent risk factors for poor adherence.
Cross-Sectional (n=488)
No
What is the adherence level to antihypertensive treatment and its associated risk factors in Chinese hypertensive patients?
Treatment adherence among hypertensive patients in China is poor (27.46%), highlighting the need for targeted educational strategies and lifestyle modification emphasis.
To assess the adherence level of antihypertensive treatment and identify any associated risk factors in a sample of hypertensive patients from China.A cross-sectional study involving 488 Chinese hypertensive patients was conducted in a tertiary hospital in Xi'an, China. Data were collected regarding socio-demographic factors and hypertension-related clinical characteristics. The adherence to treatment was assessed using the previously validated instrument: therapeutic adherence scale for hypertensive patients.A total of 27.46% of patients were compliant with their antihypertensive treatments. Three factors were identified to be independently associated with antihypertensive treatment adherence: gender (P = .034), residence (P = .029), duration of high blood pressure (P < .001). Gender, residence, occupation, and the duration of antihypertensive drugs treatment used were found to have significant effects on treatment adherence in certain categories.Treatment adherence among hypertensive patients in China was poor. More attention and effective strategies should be designed to address factors affecting treatment adherence. Education about hypertension knowledge should be strengthened for patients. Moreover, the importance of lifestyle modification during hypertension treatment is often neglected by patients, therefore, there is an urgent need to educate hypertensive patients about the adherence to lifestyle modifications.
Pan et al. (Mon,) conducted a cross-sectional in Primary hypertension (n=488). Antihypertensive treatment was evaluated on Satisfactory adherence to antihypertensive treatment (TASHP score ≥109). Among Chinese hypertensive patients, only 27.46% demonstrated satisfactory adherence to their antihypertensive treatment, with male gender, rural residence, and shorter disease duration identified as independent risk factors for poor adherence.